Form 4: Lemaitre Vascular Director's Routine Stock Transactions
Insider Transaction Report
Lemaitre Vascular's President and Director, David B. Roberts, reported routine stock acquisitions from equity awards and dispositions for tax withholding.
Summary
- David B. Roberts, President and Director of Lemaitre Vascular Inc. (LMAT), reported multiple transactions on December 8, 2025.
- Roberts acquired a total of 20 shares of common stock at a price of $0, resulting from the release of dividend equivalent rights associated with previously granted restricted stock units (RSUs) and performance stock units (PSUs).
- Roberts disposed of a total of 435 shares of common stock at a price of $82.93 per share. These dispositions were for tax withholding obligations incurred upon the vesting of RSUs and PSUs awarded on December 8, 2023.
- Following these transactions, Roberts' direct beneficial ownership of Lemaitre Vascular Inc. common stock is 21,397 shares.
- The net change in direct beneficial ownership of common stock was a decrease of 415 shares.
Sentiment
Score: 5
Explanation: The filing reports routine, non-discretionary insider transactions related to the vesting of equity awards and subsequent tax withholding, which are neutral in terms of company performance or outlook.
Positives
- Vesting of 20 shares from dividend equivalent rights, indicating successful achievement of conditions for equity awards.
- Vesting of restricted stock units (RSUs) and performance stock units (PSUs) granted on December 8, 2023, demonstrating the fulfillment of compensation milestones.
Negatives
- Disposition of 435 shares of common stock for tax withholding purposes, reducing the direct beneficial ownership of the insider.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.
Industry Context
This filing details routine insider transactions specific to an individual executive's equity compensation and does not provide information related to broader industry trends or competitive landscape.
Stakeholder Impact
- Shareholders: Minor, routine impact as these are expected transactions related to executive compensation and do not reflect discretionary trading based on new material information.
Key Dates
| Date | Description |
|---|---|
| 12/08/2023 | Grant date of restricted stock units (RSUs) and performance stock units (PSUs) to the reporting person. |
| 12/08/2025 | Date of reported transactions, including acquisition of shares from dividend equivalent rights and disposition of shares for tax withholding. |
| 12/10/2025 | Date the Form 4 filing was signed. |
Recommendation
holdThe Form 4 filing details routine insider transactions (vesting of equity awards and tax withholding) that are expected and do not provide new material information regarding the company's operational performance, strategic direction, or future prospects. As such, it does not warrant a change in investment recommendation based solely on this report.
Keywords
LEMAITRE VASCULAR, LMAT, Form 4, insider trading, stock transactions, director, officer, common stock, dividend equivalent rights, restricted stock units, performance stock units, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.